Loading...
Market
Will the FDA issue a recall for Dexcom Stelo by the end of 2024?
4
Resolution / Starting Odds
Yes • 50%
No • 50%
FDA official announcements or recall notices
Story
Dexcom Launches First OTC Glucose Monitor in U.S.
Aug 26, 2024, 10:06 AM
Dexcom has launched Stelo, the first over-the-counter continuous glucose monitor (CGM) in the United States. The device, announced earlier this year at CES 2024, aims to provide a more affordable option for people with Type 2 diabetes to access CGMs. The availability of Stelo marks a significant step in the fight against diabetes by improving accessibility to essential monitoring technology.
View original story
Similar markets
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
